EVALUACIÓN DE LA TOXICIDAD POR GLUCORTICOIDES EN PACIENTES CON ARTRITIS REUMATOIDE Y LUPUS ERITEMATOSO SISTÉMICO EN UNA INSTITUCIÓN DE VENEZUELA
November 2024
Entrepreneurship in rheumatology
Entrepreneurship in health has become one of the sectors of greatest development not only to achieve the welfare of people, but…
Rheumatology education
To become a rheumatologist a physician must complete a prolonged training period formally defined in most of our countries, this…
Understanding the Infodemic
The COVID-19 outbreak has been accompanied by what the WHO classifies as infodemic.
The Need to Innovate
The concept of innovation is broad and its implications are diverse. But what is medical innovation and what are its developments?
New Way of Treating Patients
Discuss how the clinic responded to the need to evaluate patients in non-presential environments.
A look to COVID-19 vaccine from rheumatology
To return to the so-called “new normal” the solution is in a COVID-19 vaccine.
The now of scientific events in rheumatology
In 2020, one by one, the scientific events in all areas of knowledge scheduled to take place, on a personal-attendance basis,…
A coffee for rehumatology
Welcome to A coffee for rheumatology, the podcast of Global Rheumatology by PANLAR (GRP) where you will hear different…
